Dow Up 0.36% Nasdaq Up 0.32%

AbbVie Inc. (ABBV)

-NYSE
59.65 Up 0.20(0.34%) 10:13AM EDT - NYSE Real Time Price
Prev Close:59.45
Open:59.84
Bid:59.70 x 1600
Ask:59.72 x 1000
1y Target Est:67.38
Beta:1.928
Earnings Date:Oct 23 - Oct 27 (Est.)
Day's Range:59.63 - 59.93
52wk Range:44.02 - 60.02
Volume:3,455,663
Avg Vol (3m):11,567,600
Market Cap:94.94B
P/E (ttm):23.21
EPS (ttm):2.57
Div & Yield:1.68 (3.20%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ABBV

Comparison

Symbol% ChgMkt Cap
ABBVUp 0.34%94.94B
MRKUp 0.63%175.07B
NVSDown 1.13%227.40B
PFEDown 0.16%193.59B

Key Statistics

Forward P/E (1 yr):15.27
P/S (ttm):4.91
Ex-Dividend Date:11-Jul-14

Analysts

Annual EPS Est (Dec-14) :3.16
Quarterly EPS Est (Sep-14) :0.77
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback